Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia

Am J Hematol. 2005 May;79(1):79-80. doi: 10.1002/ajh.20274.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Blood Cell Count
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnostic imaging
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Lymphatic Diseases / chemically induced*
  • Lymphatic Diseases / diagnostic imaging
  • Middle Aged
  • Piperazines / adverse effects*
  • Pleural Effusion / chemically induced
  • Pleural Effusion / diagnostic imaging
  • Pyrimidines / adverse effects*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate